A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)

S. Stacchiotti, J. Y. Blay, R. L. Jones, G. D.D. Demetri, O. Mir, A. Italiano, D. Thomas, T. W.W. Chen, P. Schöffski, T. Gil, T. Jahan, G. Cote, R. Ratan, S. Attia, M. Roche, S. Daigle, I. Sapir, A. Clawson, M. Gounder

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii580
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this